Switzerland· 54746024
Neurodol Tissugel, cerotto medicato
A lidocaine product containing lidocainum, registered in Switzerland by IBSA Institut Biochimique SA and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Lidocaine is registered in 11 of 19 countries.
Countries holding a registration under ATC D04AB01 (lidocaine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 6 of them publish a price we can compare per daily dose
Lidocaine · ATC D04AB01
11 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- lidocainum
- Manufacturer
- IBSA Institut Biochimique SA
- Country
- Switzerland (CH)
- ATC code
- D04AB01
- ATC class
- Lidocaine
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768054746024110 StkCHF 36.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
39 interactions on record for lidocaine.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lidocaine · interactions on record
39 records
- 1 severe
- 38 moderate
Most severe, free to view
- PrilocaineN01BB04severe
- MetoclopramideA03FA01moderate
- SulfamethizoleB05CA04moderate
- Glyceryl trinitrateC01DA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0568476b-ab24-4462-aa5f-b985493ac87e GET /v1/drugs/0568476b-ab24-4462-aa5f-b985493ac87e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "lidocainum 700 mg",
"valid_from": "2003-12-01",
"limitations": null,
"galenic_form": "Pfl",
"therapeutic_area": null,
"sl_inclusion_date": "2003-12-01",
"self_retention_pct": 10
}See everything about lidocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.